ArticleEMBO molecular medicine2020

RIPK1-mediated immunogenic cell death promotes anti-tumour immunity against soft-tissue sarcoma.

Henry G Smith et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.